---
category: news
title: "Ardigen Enters Into Research Collaboration With CVC to Apply Artificial Intelligence for Identification of T-cell Targets"
excerpt: "KRAKÓW, Poland and AUCKLAND, New Zealand, July 9, 2020 /PRNewswire/ -- Ardigen and CVC announced that they entered a research collaboration aimed at the development of SARS-CoV-2 vaccine. Ardigen’s neoantigen prediction platform called “ArdImmune Vax” employs state of the art bioinformatics and Artificial Intelligence to identify an optimal set of neoantigens as targets for cancer vaccines or adoptive cell therapies."
publishedDateTime: 2020-07-09T13:00:00Z
webUrl: "https://apnews.com/PR Newswire/f8f11b08d83d939cd0e4273154936610"
type: article
quality: 12
heat: 12
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "EHF8OgojhcKjsxYUsiZALZWfjV4z1ySAVWNjp957xAyHw5D65IuTR/rMwZ7tgelMGNqDL/rymi7OBU9wLGJnSOO2Ea0LUkui5XbgVfHd4aIcnhZ3rBKGdeHvKECEe+tf7KF9TvJo1j6rId7/V/ZjnrucmuPGa/cOwKfQMDeIyoN1agZcBctLUJlvMr1v2PWqs7HQBAFSnezmEbtALYkQOzHG76sfuDFEkXUz/bEKyJZV1PfyaCNbaQBQ/DruAdlC5k7LrVvfloPilOSwo4BgZRLf+FR1I+QRUfW+7X9vRHaG2kU3/IEgb5NqgZj53AuyeVd0tcottG81A42own4r7g==;J2pe6VzvSfd5Q3NE4qzPfA=="
---

